SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Proposal For Italian Guidelines in Pharmacoeconomics
10 references·2 citing·42 second hop
A Proposal For Italian Guidelines in Pharmacoeconomics (1995)A Proposal For Italian Guidelines in Phar…Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Uncertainty in the economic e…Indirect Costs in Economic Studies (1993)Indirect Costs in Economic St…Guidelines for Economic Analysis of Pharmaceutical Products (1993)Guidelines for Economic Analy…Cost effectiveness/utility analyses (1992)Cost effectiveness/utility an…Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)Economic Analysis Alongside C…Meta-Analysis in Clinical Research (1987)Meta-Analysis in Clinical Res…Measurement of health state utilities for economic appraisal (1986)Measurement of health state u…Economics, medicine, and health care (1986)Economics, medicine, and heal…Discounting of Life-Saving and Other Nonmonetary Effects (1983)Discounting of Life-Saving an…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Foundations of Cost-Effective…Budget impact analysis in economic evaluation: a proposal for a clearer definition (2011)Budget impact analysis in eco…Reporting Format for Economic Evaluation (1998)Reporting Format for Economic…Economics of coronary artery bypass grafting. (1985)Cost-of-Illness Studies (1992)Estimates of the lifetime costs of breast cancer treatment in Canada (2000)Methods for the Economic Evaluation of Health Care Programmes (2005)Valuing Patient and Caregiver Time (2005)Do Productivity Costs Matter? (2011)Methods for the economic evaluation of health care programmes (1987)Cost-effectiveness league tables: More harm than good? (1993)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial (2016)Social Choice and Individual Values. (1951)Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life (1989)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Conducting Discrete Choice Experiments to Inform Healthcare Decision Making (2008)Theory of games and economic behavior (2019)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Interpreting the Results of Cost-Effectiveness Studies (2008)Utilities and Quality-Adjusted Life Years (1989)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Confidence intervals for cost/effectiveness ratios (1995)Cost-effectiveness of captopril therapy after myocardial infarction (1995)Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care. (1998)The Distinction Between Cost and Charges (1982)Utility approach to measuring health-related quality of life (1987)Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods (1997)Introducing economic and quality of life measurements into clinical studies (2001)A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries (2004)The file drawer problem and tolerance for null results. (1979)A method for assessing the quality of a randomized control trial (1981)Meta-analysis in clinical trials (1986)Publication bias in meta-analysis its causes and consequences (2000)THE FILE-DRAWER PROBLEM REVISITED: A GENERAL WEIGHTED METHOD FOR CALCULATING FAIL-SAFE NUMBERS IN META-ANALYSIS (2005)Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? (2010)Cost-utility in practice: A policy maker's guide to the state of the art (1992)Chapter 2 An overview of the normative economics of the health sector (2000)Valuing the benefits and costs of health care programmes: where's the ‘extra’ in extra-welfarism? (2003)Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost–benefit analysis? (1999)Is American Health Care Uniquely Inefficient? (2008)On discount rates for economic evaluations in global health (2019)Recommendations for Reporting Cost-effectiveness Analyses (1996)
this work references cited by second hop

References

  • 1986Measurement of health state utilities for economic appraisal2,204 cited
  • 1977Foundations of Cost-Effectiveness Analysis for Health and Medical Practices2,118 cited
  • 1987Meta-Analysis in Clinical Research1,267 cited
  • 1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis521 cited
  • 1991Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues337 cited
  • 1983Discounting of Life-Saving and Other Nonmonetary Effects277 cited
  • 1992Cost effectiveness/utility analyses277 cited
  • 1986Economics, medicine, and health care200 cited
  • 1993Indirect Costs in Economic Studies170 cited
  • 1993Guidelines for Economic Analysis of Pharmaceutical Products142 cited

Cited by

  • 1998Reporting Format for Economic Evaluation74 cited
  • 2011Budget impact analysis in economic evaluation: a proposal for a clearer definition74 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work